|
Catalogue
Number
|
Product
|
Order number / Unit
|
|
|
5200
|
Desmethyl-PD 153035
|
5200.0001: 1 mg per vial
Please inquire for customized
filling and bulk quantities.
|
|
|
Precursor for [Methoxy-11C]PD 153035
Potent and specific inhibitor of the EFG receptor tyrosine kinase
|
|
|
|
|
|
|
|
|
Molar Mass: 346.18
|
|
|
C15H12BrN3O2
|
|
|
[295330-61-9]
|
|
|
|
|
|
Yellowish solid packaged in dark glass crimp cap vials.
|
|
|
|
|
|
|
|
|
Purity: > 95 %
|
|
|
Certificates:
CoA; 1H NMR spectrum
|
|
|
Chemical Name:
CA index name: 6-Quinazolinol, 4-[(3-bromophenyl)amino]-7-methoxy-
|
|
|
Synonymes:
4-Quinazolinamine, N-(3-bromphenyl)-6-hydroxy-7-methoxy-; 4-(3-Bromophenylamino)-7-methoxyquinazolin-6-ol; 4-[(3-Bromophenyl)amino]-6-hydroxy-7-methoxyquinazoline
|
|
|
Literature:
1. Fredriksson A. et al. In vivo evaluation of the biodistribution of 11C-labeled PD153035 in rats without and with neuroblastoma implants Life Sci. 1999, 65, 165-174.
|
|
|
2. Johnström P. et al. Synthesis of [Methoxy-11C]PD153035, a Selective EGF Receptor Tyrosine Kinase Inhibitor J. Labelled Compd. Radiopharm. 1998, 41, 623-629.
|
|
|
3. Gibson K.H. et al. Epidermal growth factor receptor tyrosine kinase: Structure-activity relationships and antitumour activity of novel quinazolines Bioorg. Med. Chem. Lett. 1997, 7, 2723-2728.
|
|
|
|
|
|
|
|
|
date of product catalogue issue:
05 April 2012
|